Tag

Screening Guidelines

All articles tagged with #screening guidelines

Hidden Onset: Barrett's Esophagus Likely Begins in Early Adulthood
health14 days ago

Hidden Onset: Barrett's Esophagus Likely Begins in Early Adulthood

Researchers using an esophagus-specific epigenetic clock analyzed UK cohorts and estimate that Barrett's esophagus often begins in early adulthood (roughly ages 20–30), decades before clinical diagnosis, creating a long premalignant window that may accumulate cancer-driving mutations and suggesting a shift toward personalized, continuous-risk screening rather than strict age cutoffs; however, broad screening of all GERD patients could lead to oversurveillance.

Subtle Prostate Cancer Signs Highlight Need for Regular Screening
health18 days ago

Subtle Prostate Cancer Signs Highlight Need for Regular Screening

Prostate cancer is projected to be the most diagnosed cancer among U.S. men in 2026, and its early signs can be subtle or absent. Common symptoms include frequent urination (especially at night), difficulty starting urination, a burning sensation when urinating, blood in urine or semen, and erectile problems; two often-missed signs are a persistent feeling of incomplete bladder emptying and pelvic or lower back pain, which can indicate spread. Regular PSA screening is recommended—start at age 50 for average risk (40–45 for higher risk) and repeat every 2–3 years; persistent symptoms should prompt a urologist visit. Early detection offers more curative treatment options such as surgery or radiation.

Colonoscopy Is the Gold Standard Gut Health Test, Doctor Says
health1 month ago

Colonoscopy Is the Gold Standard Gut Health Test, Doctor Says

A GI doctor says colonoscopy is the No. 1 test to know if your gut is healthy because it can prevent colorectal cancer by removing polyps; for average-risk adults, start screening at 45 and have a colonoscopy every 10 years, with additional lifestyle steps (high-fiber diet around 28 g/day, regular physical activity, no smoking or excessive alcohol) and routine checkups to reduce risk.

Family history matters as cancers rise among younger Americans
health2 months ago

Family history matters as cancers rise among younger Americans

More cancers are rising in adults under 50, notably colorectal and breast cancer; a survivor’s story shows how family history and early symptom reporting can save lives, while doctors tailor earlier screenings and caution against relying on at‑home tests; screening ages are evolving—mammograms to 40, colonoscopy to 45 for average risk—making ongoing clinician guidance essential.

US Expands Colorectal Cancer Screening with At-Home and Blood Tests
health2 months ago

US Expands Colorectal Cancer Screening with At-Home and Blood Tests

The American Cancer Society updated its May 2026 colorectal cancer screening guidelines to add two new options—an at-home stool test and a blood-based test—while maintaining colonoscopy as a primary option. Average-risk individuals should start screening at age 45 and continue until 75 (or longer if advised by a doctor). The stool and blood tests are intended to improve access and early detection, though many doctors’ offices may not yet offer them; ultimately, the best test is the one that gets done, with colonoscopy remaining the default for those with higher risk or abnormal results.

Blood Tests Enter Colorectal Cancer Screening Guidelines
health3 months ago

Blood Tests Enter Colorectal Cancer Screening Guidelines

The American Cancer Society has added blood-based screening to its colorectal cancer guideline for adults 45+ at average risk who decline or have not completed visual exams or stool tests, endorsing Guardant Health's Shield blood test alongside at-home stool tests such as Cologuard Plus and ColoSense; however, blood-based tests are less sensitive for precancerous polyps and are considered a secondary option when other tests aren't completed, with colonoscopy remaining the gold standard.

Blood Test Joins Colorectal Cancer Screening to Reach the Underscreened
health3 months ago

Blood Test Joins Colorectal Cancer Screening to Reach the Underscreened

The American Cancer Society added the Shield blood test as a recommended option for colorectal cancer screening for people who can’t or won’t have colonoscopies or stool tests. It’s not a replacement for colonoscopy; it’s intended to increase screening among the under-screened. The Shield test detects DNA fragments from tumors and, while about 83% effective at detecting existing cancer, is less reliable for early-stage disease and precancerous polyps. It costs $895 out of pocket and insurance coverage isn’t guaranteed. Most doctors stress that colonoscopy remains the gold standard and screening options vary (stool tests, Cologuard/ColoSense) with follow-up colonoscopy required if a test is positive. Experts say expanding options could boost uptake, since screening should start at 45 for average risk.

ACS Brings Blood Screening Into Colorectal Cancer Guidelines
health3 months ago

ACS Brings Blood Screening Into Colorectal Cancer Guidelines

ACS updates colorectal cancer screening guidelines to include a blood-based test (the Shield test) for average-risk adults 45+ who decline visual or stool tests; Shield detects tumor DNA in blood with about 83% sensitivity for cancer and is recommended every three years, but is less sensitive for precancerous polyps, so it is not the first choice. The update also adds at-home stool tests (Cologuard Plus, ColoSense) and maintains colonoscopy as the gold standard. The aim is to boost screening rates, especially among younger adults, with Medicare coverage offering no co-pay for Shield for many beneficiaries.

health3 months ago

Mammogram Timing Clash: Start Age and Frequency Vary by Guideline

Guidelines for routine breast screening differ: ACP recommends average‑risk women start at 50–74 with biennial mammograms, USPSTF suggests starting at 40 with the same 2‑year interval, and ACS has long urged yearly screening starting at 45 (with 40 optional) and then switching to every year or every other year for older women. The disagreement reflects challenges in predicting risk and balancing benefits with harms, especially since dense breasts and tumor biology vary. New research (like the WISDOM trial) and tools to assess individual risk could tailor schedules in the future, including the potential use of DBT and broader gene testing. For now, consult a doctor about personal risk and stick with a chosen screening plan.

Mammogram timing diverges as experts push toward personalized screening
health3 months ago

Mammogram timing diverges as experts push toward personalized screening

Guidelines on when to start and how often to screen with mammograms clash among major groups, reflecting imperfect risk prediction. ACP recommends average-risk women 50–74 get mammograms every two years, with 40–49 discussing pros/cons; USPSTF starts at 40 every two years; ACS favors yearly screening for 45–54 (start at 40 optional) and allows switching after 55. Dense breasts and emerging tools like 3D mammography, broader genetic risk tests, and AI risk models may tailor later practice, but experts say regular screening remains most beneficial when a shared plan is followed with a clinician.

Never-smoker lung cancer on the rise as genetics and pollution drive new cases
health4 months ago

Never-smoker lung cancer on the rise as genetics and pollution drive new cases

Lung cancer is increasingly diagnosed in healthy, non-smokers—often younger women—driven by genetic changes like ALK and environmental factors such as air pollution and burn-pit toxins; experts urge expanding screening beyond smoking history and highlight targeted therapies that can turn advanced disease into a manageable condition.

Rectal Cancer Surges Among Younger Adults, Prompting Screening Reconsideration
health5 months ago

Rectal Cancer Surges Among Younger Adults, Prompting Screening Reconsideration

A new American Cancer Society report finds rectal cancer rates are rising across ages and are driving an uptick in colorectal cancer diagnoses among people under 65 in the U.S., with rectal cancers now making up about a third of cases. From 2018–2022, rectal cancer rose about 1% annually in all ages, while younger groups saw faster increases (up to 3% for ages 20–49). The trend is prompting discussion on screening age (USPSTF has lowered it to 45) and faster symptom education/referrals, as many under-50 patients are diagnosed at advanced stages. Emphasized risk factors include smoking, excess weight, physical inactivity, and diet; reducing these could help lower risk.

Colorectal Cancer Goes Younger: Nearly Half of New Cases Are Under 65
health5 months ago

Colorectal Cancer Goes Younger: Nearly Half of New Cases Are Under 65

New American Cancer Society data show nearly half of colorectal cancers now occur in adults under 65, with rising cases in ages 50–64 and a notable increase in rectal cancer, likely reflecting a birth-cohort effect and environmental influences; experts emphasize paying attention to symptoms and that screening for average risk starts at age 45, while treatment varies by stage and may involve surgery, chemotherapy, and radiation for rectal cancer.

Colorectal cancer screening moves younger: why 45 is the new starting age and what to expect
health6 months ago

Colorectal cancer screening moves younger: why 45 is the new starting age and what to expect

The piece explains that colorectal cancer is increasingly affecting younger people, leading to guidelines that now start average-risk screening at age 45 with a colonoscopy every 10 years (or stool tests as alternatives), notes that a family or personal history can trigger earlier testing, and discusses symptoms, costs, and the role of noninvasive tests like Cologuard and FIT. It also highlights that lifestyle factors and access to care influence risk and screening uptake.